Urolithiasis is a common problem causing considerable morbidity and medical care costs. The annual incidence of clinical stone disease is approximately 1 per 1000 in the adult population; about 1 in 10 Americans will require treatment for a stone during his or her lifetime (1-3). Recurrences are common, occurring among 20% to 50% of patients within a 5-year period (4-6). Fortunately, most stones are small enough to pass spontaneously (5-7). In such cases, the major costs are indirect, due to the substantial morbidity produced in an otherwise healthy, productive segment of the population (most first episodes occur between 30 and
Lithotripsy. Ann Intern Med. ;103:626–629. doi: 10.7326/0003-4819-103-4-626
Download citation file:
Published: Ann Intern Med. 1985;103(4):626-629.
Healthcare Delivery and Policy, Prevention/Screening.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use